OPS) 16 Sales Adjusted EBITDA $818 $823 2021 2022 + 1% Adjusted EPS + 8% - 3% (in millions) (in millions) (+ 9% excluding FX) (+ 18% excluding FX) (+ 5% excluding FX) Q3 EBITDA BRIDGE (PRO FORMA TOTAL COMPANY) 17 Price increases more than offset raw material and supply chain impacts $ millions CAI: Price / Mix 68 Inflation (44) SEM: Price / Mix 41 Inflation (26) Net Price Benefit 39 Wage and Energy Inflation (14) Clariant Color Integration Synergies 6 Incentives, Other Employee Costs 14 FX (11) Q3 2022 $137   Adjusted EBITDA Q3 2021 $ 142 Demand (39) Q3 2022 SEGMENT PERFORMANCE 18 CAI $587 $566 Sales ($ in millions) $93 $93 EBITDA SEM Pro Forma $326 $319 Sales $70 $62 EBITDA (+ 4% excluding FX) - 4% - 2% (+ 5% excluding FX) Flat (+ 7% excluding FX) - 11% (- 7% excluding FX) $500 $585 Cont. Sales EBITDA Specialty Engineered Materials Color Additives and Inks $585M$3,635M (1) Transportation 9% Healthcare 8% 23 C O L O R , A D D I T I V E S & I N K S 2022 REVENUE | $2 .3 B ILL ION US & Canada 35% EMEA 40% Asia 20% Latin America 5% END MARKET REGION 24 Packaging 33% Consumer 22% Healthcare 9% Industrial 15% Transportation 8% Building & Construction 11% Telecommunications 1% Energy 1% Figures represent 2022 full year estimates S P E C I A LT Y E N G I N E E R E D M AT E R I A L S 2022 PRO FORMA REVENUE | $1 .3 B ILL ION END MARKET US & Canada 50% EMEA 35% Asia 15% REGION 25 Figures represent 2022 full year estimates Packaging 5% Consumer 19% Healthcare 8%Industrial 16% Transportation 10% Telecommunications 10% Energy 9% Defense 15% Building & Construction 8% Packaging 31% Consumer 28% Healthcare 8% Industrial 13% Building & Construction 5% Telecommunications 3% Energy 2% Defense 1% Asia (20% of sales) Transportation 9% 2022 PROFORMA AVIENT REGIONAL SALES BY END MARKET Packaging 29% Consumer 13% Healthcare 5% Industrial 17% Building & Construction 11% Energy 5% Defense 7% EMEA (35% of sales) Transportation 10% Packaging 14% Consumer 23% Healthcare 11% Industrial 15% Building & Construction 12% Energy 5% Defense 7% US & Canada (40% of sales) Transportation 7% Packaging 49% Consumer 22% Healthcare 8% Industrial 9% Building & Construction 6% Telecommunications 1% LATAM (5% of sales) Transportation 5% Telecommunications 3%Telecommunications 6% Figures represent 2022 full year estimates Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results. The Q3 2022 "Pro Forma APM" adjustments reflect periods prior to the acquisition date and are preliminary estimates for APM’s results for the months of July and August. 3 AVNT Q3 2022 Earnings Presentation - Website v2.pdf AVNT Q3 2022 Earnings Presentation - Website Update.pdf AVNT Q3 2022 Earnings Presentation - Website.pdf 11.7 823am IR Deck - AVNT-2022.09.30 (002).pdf

KEY CHARACTERISTICS ECCOH 5924 FORMULATION ECCOH 5981 FORMULATION ECCOH 5983 UV FORMULATION Material Standards BS7655-6, 1 (LTS1–4), BS6724, IEC 60502 BS7655-6, 1 (LTS3) BS7655-6, 1 (LTS1–4) Tear Strength at 23°C 7.7 N/mm 10 N/mm 11 N/mm Tear Strength at 65°C 2.3 N/mm 5 N/mm 6.5 N/mm Hot Pressure Test (6h at 90°C) 39% –

FIBER-LINE™ High Performance Synthetic Fibers PRODUCT SELECTION GUIDE FIBER-LINE™ HIGH PERFORMANCE SYNTHETIC FIBERS Kevlar® Para-Aramid Nomex® Meta-Aramid Vectran® LCP Zylon® PBO Carbon Fiber UHMWPE PET Polyester Fiberglass Novoloid Technora® Filament Yarn TECHNICAL PROPERTIES Standard Modulus High Modulus Standard Modulus Standard Modulus High Modulus Standard Modulus High Modulus Standard Modulus Standard Modulus High Modulus High Tenacity Low Shrink E-Glass S-Glass Standard Modulus Standard Modulus Breaking Tenacity (g/d) 23.0 23.6 5.0 23.0 30.0 42.0 42.0 23.0 28.0 38 9.3 8.4 6.0 - 7.3 6.7 - 9.4 1.5 28.0 Specific Gravity (Ratio) 1.44 1.44 1.38 1.40 1.40 1.54 1.56 1.80 0.97 0.97 1.38 1.38 2.58 2.48 1.27 1.39 Elongation at Break (%) 3.5 2.5 30.0 3.8 2.8 3.5 2.5 1.5 3.5 3.1 14.6 19.5 3.5 5.5 30.0 - 40.0 4.6 Tensile Modulus (g/d) 555 885 125 600 830 1200 1800 1480 850 1250 120 70 200–275 140–170 2.5–5.0 590 Equilibrium Moisture Regain at 55% RH (%) 5.0 5.0 4.5

Additional draft may be required for grained/textured surfaces. 3 NYMAX BIO TROUBLESHOOTING Implement recommended solutions one at a time in the order specified until problem is resolved. Decrease back pressure 3. Reduce screw speed 3.

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. PolyOne Corporation Page 3 Use of Non-GAAP Measures  This presentation includes the use of both GAAP (generally accepted accounting principles) and non-GAAP financial measures. S&P 500 PolyOne Corporation Page 9 2006 Q1 2015 2020 “Where we were” “Where we are” Platinum Vision 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 16.2% 20%+ Global Specialty Engineered Materials 1.1% 16.3% 20%+ Designed Structures & Solutions 1.4% (2012) 2.7% 12 – 14% Performance Products & Solutions 5.5% 6.5% 10 – 12% Distribution 2.6% 5.9% 6.5 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 69% 80%+ 3) ROIC 5.0% 11.4% 15% 4) Adjusted EPS Growth N/A 22 Consecutive Quarters of EPS Growth Double Digit Expansion Proof of Performance & 2020 Goals PolyOne Corporation Page 10 Platinum Vision: Pathway to Accelerated Growth Organic Sales Growth Margin Expansion Share Repurchases Acquisitions PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2014 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 27% 2006 2014 Specialty Platform Gross Margin % 20% 44% 2006 2014 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 12 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 13 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 6 9 7 3 5 12 5 3 2 8 4 2 4 3 1 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 14 8 18 12 22 74 Addressable Market ($ millions) $700 $600 $600 $1,900 PolyOne Corporation Page 14 60% 98% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 Q1 2015 Pension Funding** As of March 31, 2015 Debt Maturities & Pension Funding Net Debt / EBITDA* = 2.1x $49 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2015 ($ millions) Coupon Rate: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2015 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return  Expanding our sales, marketing, and technical capabilities  Investing in operational and LSS initiatives  ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend  Targets that expand our: • Specialty offerings • End market presence • Geographic breadth  Synergy opportunities  Adjacent material solutions  Repurchased over 500k shares in Q1 2015  Repurchased 11.8 million shares since early 2013  8.2 million shares are available for repurchase under the current authorization PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

2018, PolyOne plans to present additional details about design and materials innovation in the outdoor high-performance market as one of several high-growth focus areas that underpin the company's expectation of delivering double digit EPS growth in 2018 and beyond. 

We are very confident in our future growth potential and delivering double-digit EPS expansion in 2018 and beyond, and look forward to sharing our plans and expectations in these areas with our investors," said Mr.

Mecall, part of the GMM Group, is a leading manufacturer of X-ray equipment for the healthcare industry including radiographic systems, digital angiography equipment, remote-controlled tilting systems and more.

Lima, Peru 8. Berea, Ohio 38. Berea, Ohio 38.

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. PolyOne Corporation Page 3 Use of Non-GAAP Measures  This presentation includes the use of both GAAP (generally accepted accounting principles) and non-GAAP financial measures in certain cases throughout this presentation. S&P 500 PolyOne Corporation Page 9 2006 Q1 2015 2015 Target “Where we were” “Where we are” (Est. in 2012) 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 16.2% 12 – 16% Global Specialty Engineered Materials 1.1% 16.3% 12 – 16% Designed Structures & Solutions 1.4% (2012) 2.7% 8 – 10% Performance Products & Solutions 5.5% 6.5% 9 – 12% Distribution 2.6% 5.9% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 69% 65 – 75% 3) ROIC 5.0% 11.4% 15% 4) Adjusted EPS Growth N/A 5% Double Digit Expansion Proof of Performance & 2015 Goals PolyOne Corporation Page 10 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2014 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 27% 2006 2014 Specialty Platform Gross Margin % 20% 44% 2006 2014 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 11 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) $800 $450 $450 $1,700 PolyOne Corporation Page 13 60% 98% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 Q1 2015 Pension Funding** As of March 31, 2015 Debt Maturities & Pension Funding – 3/31/15 Net Debt / EBITDA* = 2.1x $49 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2015 ($ millions) Coupon Rate: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2015 PolyOne Corporation Page 14 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return  Expanding our sales, marketing, and technical capabilities  Investing in operational and LSS initiatives  ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend  Targets that expand our: • Specialty offerings • End market presence • Geographic breadth  Synergy opportunities  Adjacent material solutions  Repurchased over 500k shares in Q1 2015  Repurchased 11.8 million shares since early 2013  8.2 million shares are available for repurchase under the current authorization PolyOne Corporation Page 15 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 16 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?